SCHEMBL6971985

SCHEMBL6971985

CCOC(=O)COc1cc2c(=O)ccn3c4ccc(Br)cc4c(c1)c23

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
MCL1 Q07820 1/20 0.40
ALDH1A1 P00352 4/20 0.40
POLB P06746 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
MAPK1 P28482 2/20 0.40
LMNA P02545 1/20 0.40
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
CA12 O43570 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA2B P29275 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6983135 0.87 PTGDR2 (0.39) MEN1KMT2AMCL1POLBL3MBTL1
SCHEMBL6980950 0.87 MCL1 (0.42) MEN1KMT2AMCL1ALDH1A1POLB
SCHEMBL6981400 0.87 PSEN1 (0.39) ALDH1A1POLBLMNAPSEN1PSEN2
SCHEMBL6979976 0.86 SMN1; SMN2 (0.34) SMN1; SMN2ALDH1A1LMNAGAANPSR1
SCHEMBL6983087 0.85 LMNA (0.44) SMN1; SMN2MEN1KMT2AMCL1ALDH1A1
SCHEMBL8157626 0.79 POLB (0.36) SMN1; SMN2MEN1KMT2AALDH1A1POLB
SCHEMBL7083107 0.78 IDO1 (0.33) MAPK1LMNA
SCHEMBL6982438 0.78 PIK3R1 (0.39) SMN1; SMN2MEN1KMT2AMCL1ALDH1A1
SCHEMBL6979890 0.78 CTRC (0.39) POLBL3MBTL1PSEN1PSEN2APH1B
SCHEMBL8152607 0.77 LMNA (0.36) SMN1; SMN2MEN1KMT2AMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0985671-B1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP disclosed
US-6197768-B1 THERAPY, PREVENTION ISCHEMIC HEART DISEASE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2001-03-06 US disclosed
EP-0992240-A1 THERAPEUTIC AGENT FOR ERECTION FAILURE MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-04-12 EP disclosed
EP-0985671-A1 PYRIDOCARBAZOLE DERIVATIVES HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-03-15 EP disclosed
US-6018046-A SELECTIVE ACTION IN INHIBITING CYCLIC GMP-PHOSPHODIESTERASE (CGMP-PDE); PHARMACEUTICALS FOR TREATING DISEASES AGAINST WHICH THE INHIBITORY ACTION IS EFFECTIVE, SUCH AS PULMONARY HYPERTENSION MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-01-25 US disclosed